Vor Biopharma Inc. Common Stock (VOR) is a publicly traded Healthcare sector company. As of July 22, 2026, VOR trades at $20.23 with a market cap of $945.54M and a P/E ratio of -0.28. VOR moved +15.24% today. Year to date, VOR is +53.29%; over the trailing twelve months it is -51.10%. Its 52-week range spans $2.62 to $65.80. Analyst consensus is strong buy with an average price target of $26.33. Rallies surfaces VOR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover VOR: 0 strong buy, 3 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $26.33.
| Metric | Value |
|---|---|
| Price | $20.23 |
| Market Cap | $945.54M |
| P/E Ratio | -0.28 |
| EPS | $-70.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $65.80 |
| 52-Week Low | $2.62 |
| Volume | 1.24M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-695.98M |
| Gross Margin | 0.00% |
4 analysts cover VOR: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.33.